Author： Müller T.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.18, Iss.2, 2004-01, pp. : 105-111
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Non-dopaminergic drug treatment of Parkinson’s disease
By Müller T.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. :
Access to resources
Recommend
Ropinirole in the treatment of Parkinson’s disease
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. :
Drug treatment of non-motor symptoms in Parkinson’s disease
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. :
Emerging Therapies in the Pharmacological Treatment of Parkinsons Disease
Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. :
Treatment of Psychosis in Parkinsons Disease: Safety Considerations
By Fernandez H.H. Trieschmann M.E. Friedman J.H.
Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. :